메뉴 건너뛰기
Neurology
Volumn 80, Issue 6, 2013, Pages 514-515
TPA and warfarin: Time to move forward
Author keywords

[No Author keywords available]
Indexed keywords

ACETYLSALICYLIC ACID; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;
EID: 84873649498     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827b1b7c     Document Type: Editorial
Times cited : (7)
References (6)
  • 1
    • 84862858987 scopus 로고    scopus 로고
    • Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator
    • Xian Y, Liang L, Smith EE, et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 2012;307:2600-2608.
    • (2012) JAMA , vol.307 , pp. 2600-2608
    • Xian, Y.1    Liang, L.2    Smith, E.E.3
  • 2
    • 84863603095 scopus 로고    scopus 로고
    • Subtherapeutic warfarin therapy entails an increased bleeding risk after stroke thrombolysis
    • Ruecker M, Matosevic B, Willeit P, et al. Subtherapeutic warfarin therapy entails an increased bleeding risk after stroke thrombolysis. Neurology 2012;79:31-38.
    • (2012) Neurology , vol.79 , pp. 31-38
    • Ruecker, M.1    Matosevic, B.2    Willeit, P.3
  • 3
    • 0034856495 scopus 로고    scopus 로고
    • Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke
    • Molina CA, Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke 2001;32:1079-1084.
    • (2001) Stroke , vol.32 , pp. 1079-1084
    • Molina, C.A.1    Montaner, J.2    Abilleira, S.3
  • 4
    • 0035130531 scopus 로고    scopus 로고
    • Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
    • Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-441.
    • (2001) Stroke , vol.32 , pp. 438-441
    • Larrue, V.1    Von Kummer, R.R.2    Muller, A.3    Bluhmki, E.4
  • 5
    • 84861613750 scopus 로고    scopus 로고
    • Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: Safe implementation of treatments in stroke (sits) symptomatic intracerebral hemorrhage risk score
    • Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: Safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 2012;43:1524-1531.
    • (2012) Stroke , vol.43 , pp. 1524-1531
    • Mazya, M.1    Egido, J.A.2    Ford, G.A.3
  • 6
    • 0027406472 scopus 로고
    • Hemorrhagic transformation in cardioembolic cerebral infarction
    • Hornig CR, Bauer T, Simon C, Trittmacher S, Dorndorf W. Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 1993;24:465-468.
    • (1993) Stroke , vol.24 , pp. 465-468
    • Hornig, C.R.1    Bauer, T.2    Simon, C.3    Trittmacher, S.4    Dorndorf, W.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.